Pulmonary Medicine

Pulmonary Medicine Publications

  1. Beebe DW, Rausch J, Byars KC, Lanphear B, Yolton K. Persistent snoring in preschool children: predictors and behavioral and developmental correlates. Pediatrics. 2012; 130:382-9.
  2. Burt RS, Meltzer DO, Seid M, Borgert A, Chung JW, Colletti RB, Dellal G, Kahn SA, Kaplan HC, Peterson LE, Margolis P. What's in a name generator? Choosing the right name generators for social network surveys in healthcare quality and safety research. BMJ Qual Saf. 2012; 21:992-1000.
  3. Castro M, Woods J. Insights into pediatric asthma with hyperpolarized magnetic resonance imaging of the lung. J Allergy Clin Immunol. 2013; 131:377-8.
  4. Chaudhry H, Brockbank J, Vandyke R, Fenchel M, Dixon M, Amin R, Simakajornboon N. Night to Night Variability of Polysomnographic Parameters in Obese Children and Adolescents with Obstructive Sleep Apnea (Osa). Sleep. 2012; 35:A352-A352.
  5. Clancy JP, Donaldson S, Gabriel S, Hornick D, Starner TD, Rowe S, VanDyke R, Fenchel M, Sun H. Centralized Intestinal Current Measurements (Icm): Cftr Activity in Fresh and Cold-Stored Rectal Biopsies, and Comparison of Forceps Vs Suction Biopsy. Pediatric Pulmonology. 2012; 47:296-296.
  6. Clancy JP, Jain M. Personalized Medicine in Cystic Fibrosis Dawning of a New Era. American Journal of Respiratory and Critical Care Medicine. 2012; 186:593-597.
  7. Crisalli JA, McConnell K, Vandyke RD, Fenchel MC, Somers VK, Shamszumann A, Chini B, Daniels SR, Amin RS. Baroreflex sensitivity after adenotonsillectomy in children with obstructive sleep apnea during wakefulness and sleep. Sleep. 2012; 35:1335-43.
  8. Field MJ, Ellinger LK, Boat TF. IOM Review of FDA--approved biologics labeled or studied for pediatric use. Pediatrics. 2013; 131:328-35.
  9. Fleck RJ, Mahmoud M, McConnell K, Shott SR, Gutmark E, Amin RS. An adverse effect of positive airway pressure on the upper airway documented with magnetic resonance imaging. JAMA Otolaryngol Head Neck Surg. 2013; 139:636-8.
  10. Foster K, Chini BA, Tan C, Crisalli J. Exercise: Perceptions of Patients with Cystic Fibrosis. Pediatric Pulmonology. 2012; 47:369-369.
  11. Gergen PJ, Teach SJ, Mitchell HE, Freishtat RF, Calatroni A, Matsui E, Kattan M, Bloomberg GR, Liu AH, Kercsmar C, O'Connor G, Pongracic J, Rivera-Sanchez Y, Morgan WJ, Sorkness CA, Binkley N, Busse W. Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. Am J Clin Nutr. 2013; 97:1228-34.
  12. Gottschlich MM, Mayes T, Khoury J, Simakajornboon N, Kagan RJ. Comparison of sleep parameters obtained from actigraphy and polysomnography during the rehabilitative phase after burn. J Burn Care Res. 2013; 34:183-90.
  13. Grossoehme DH, Cotton S, McPhail G. Use and sanctification of complementary and alternative medicine by parents of children with cystic fibrosis. J Health Care Chaplain. 2013; 19:22-32.
  14. Grossoehme DH, Cotton S, Ragsdale J, Quittner AL, McPhail G, Seid M. "I honestly believe god keeps me healthy so i can take care of my child": parental use of faith related to treatment adherence. J Health Care Chaplain. 2013; 19:66-78.
  15. Grossoehme DH, Ragsdale JR, Cotton S, Meyers MA, Clancy JP, Seid M, Joseph PM. Using spirituality after an adult CF diagnosis: cognitive reframing and adherence motivation. J Health Care Chaplain. 2012; 18:110-20.
  16. Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were chosen as a family: parents' evolving use of religion when their child has cystic fibrosis. J Relig Health. 2012; 51:1347-58.
  17. Grossoehme DH, Szczesniak R, McPhail GL, Seid M. Is adolescents' religious coping with cystic fibrosis associated with the rate of decline in pulmonary function?-A preliminary study. J Health Care Chaplain. 2013; 19:33-42.
  18. Grossoehme DH, VanDyke R, Dimitriou S, Britton LJ, McPhail GL, Seid M. Airway Clearance Adherence: Influence of Parental Spirituality and Depression. Pediatric Pulmonology. 2012; 47:435-435.
  19. Gupta S, Cepeda-Valery B, Romero-Corral A, Shamsuzzaman A, Somers VK, Pressman GS. Association between QRS duration and obstructive sleep apnea. J Clin Sleep Med. 2012; 8:649-54.
  20. Harris WT, Boyd JT, VanDyke R, Fenchel M, Brody A, McPhail GL, Clancy JP. Cf-Related Constrictive Bronchiolitis in Adolescents with Refractory Pulmonary Decline. Pediatric Pulmonology. 2012; 47:357-357.
  21. Jaacks LM, Oza-Frank R, D'Agostino R, Jr., Dolan LM, Dabelea D, Lawrence JM, Pihoker C, O'Connor MR, Linder B, Imperatore G, Seid M, Narayan KM, Mayer-Davis EJ. Migration status in relation to clinical characteristics and barriers to care among youth with diabetes in the US. J Immigr Minor Health. 2012; 14:949-58.
  22. Jacobson CJ, Farrell JE, Kashikar-Zuck S, Seid M, Verkamp E, Dewitt EM. Disclosure and self-report of emotional, social, and physical health in children and adolescents with chronic pain--a qualitative study of PROMIS pediatric measures. J Pediatr Psychol. 2013; 38:82-93.
  23. Jain SV, Horn PS, Simakajornboon N, Glauser TA. Obstructive sleep apnea and primary snoring in children with epilepsy. J Child Neurol. 2013; 28:77-82.
  24. Jain SV, Simakajornboon N, Glauser TA. Provider practices impact adequate diagnosis of sleep disorders in children with epilepsy. J Child Neurol. 2013; 28:589-95.
  25. Khan MS, Fraser CD, Morales DLS, McKenzie ED, Adachi I, Schecter MG, Mallory GB, Heinle JS. Pediatric Thoracic Multiorgan Transplantation in the United States. Journal of Heart and Lung Transplantation. 2013; 32:S151-S151.
  26. Kong M, Peng N, Jackson P, Clancy JP, Blalock E, Gaggar A. Dysregulated Matrix Metalloproteinase-9 Activity and Elevated Proline-Glycine-Proline (Pgp) Levels Are Observed in Pediatric Rsv-Induced Lung Injury. Critical Care Medicine. 2012; 40:U54-U55.
  27. Kotha K, Sun H, Ostmann A, Clancy JP. Nitric Oxide Donors Downregulate Corrected F508del Cftr and Cl- Transport in Human Airway Monolayers. Pediatric Pulmonology. 2012; 47:234-234.
  28. Lawrence JM, Yi-Frazier JP, Black MH, Anderson A, Hood K, Imperatore G, Klingensmith GJ, Naughton M, Mayer-Davis EJ, Seid M, Group SfDiYS. Demographic and clinical correlates of diabetes-related quality of life among youth with type 1 diabetes. J Pediatr. 2012; 161:201-7 e2.
  29. Lemons J, Ragsdale J, Vaughn L, Grossoehme D. "I Didn't Know It Existed Before You Called": Protestant Clergy Experience, Education and Perceptions Regarding Genetics. Journal of Genetic Counseling. 2013; 22:226-237.
  30. Lotstein DS, Seid M, Klingensmith G, Case D, Lawrence JM, Pihoker C, Dabelea D, Mayer-Davis EJ, Gilliam LK, Corathers S, Imperatore G, Dolan L, Anderson A, Bell RA, Waitzfelder B, Group SfDiYS. Transition from pediatric to adult care for youth diagnosed with type 1 diabetes in adolescence. Pediatrics. 2013; 131:e1062-70.
  31. Madala SK, Edukulla R, Davis KR, Schmidt S, Davidson C, Kitzmiller JA, Hardie WD, Korfhagen TR. Resistin-like molecule alpha1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis. Respir Res. 2012; 13:51.
  32. Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, Mitchell RB, Amin R, Katz ES, Arens R, Paruthi S, Muzumdar H, Gozal D, Thomas NH, Ware J, Beebe D, Snyder K, Elden L, Sprecher RC, Willging P, Jones D, Bent JP, Hoban T, Chervin RD, Ellenberg SS, Redline S, Childhood Adenotonsillectomy T. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013; 368:2366-76.
  33. Margolis PA, Peterson LE, Seid M. Collaborative Chronic Care Networks (C3Ns) to Transform Chronic Illness Care. Pediatrics. 2013; 131 Suppl 4:S219-23.
  34. Mayes T, Gottschlich MM, Khoury J, McCall J, Simakajornboon N, Kagan RJ. A pilot review of the long-term impact of burn injury on sleep architecture in children. J Burn Care Res. 2013; 34:e15-21.
  35. McPhail G, Clancy JP. LUMACAFTOR Corrector of CFTR Folding Treatment of Cystic Fibrosis. Drugs of the Future. 2012; 37:717-723.
  36. McPhail GL, Boesch RP, Chini BA, Fenchel M, VanDyke R, Clancy JP. Vitamin D Status Is Associated with Pulmonary Exacerbations in Children with Cystic Fibrosis. Pediatric Pulmonology. 2012; 47:364-364.
  37. McPhail GL, Boesch RP, Chini BA, Weiland J, Hoberman-Martinez A, Fenchel M, VanDyke R, Clancy JP. Improving Rapid Fev1 Decline through Quality Improvement. Pediatric Pulmonology. 2012; 47:389-389.
  38. McPhail GL, Clancy JP. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis. Drugs Today (Barc). 2013; 49:253-60.
  39. Natarajan N, Jain SV, Chaudhry H, Hallinan BE, Simakajornboon N. Narcolepsy-cataplexy: is streptococcal infection a trigger?. J Clin Sleep Med. 2013; 9:269-70.
  40. Raju SV, Jackson PL, McNicholas CM, Sloane PA, Sabbatini GM, Tang L, Mazur M, Liu B, Clancy JP, Bowen L, Accurso F, Blalock J, Dransfield M, Rowe SM. Deficits in Cftr Activity Can Be Acquired and Transmitted by a Systemic Pathway. Pediatric Pulmonology. 2012; 47:250-250.
  41. Rama JA, Fan LL, Faro A, Elidemir O, Morales DL, Heinle JS, Smith EO, Hazen ML, Moonnumakal SP, Mallory GB, Schecter MG. Lung transplantation for childhood diffuse lung disease. Pediatr Pulmonol. 2013; 48:490-6.
  42. Ratjen F, Durham T, Navratil T, Schaberg A, Accurso FJ, Wainwright C, Barnes M, Moss RB, Group T-SI. Long term effects of denufosol tetrasodium in patients with cystic fibrosis. J Cyst Fibros. 2012; 11:539-49.
  43. Rowe SM, Borowitz DS, Burns JL, Clancy JP, Donaldson SH, Retsch-Bogart G, Sagel SD, Ramsey BW. Progress in cystic fibrosis and the CF Therapeutics Development Network. Thorax. 2012; 67:882-90.
  44. Rutter MM, Collins J, Rose SR, Woo JG, Sucharew H, Sawnani H, Hor KN, Cripe LH, Wong BL. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Neuromuscul Disord. 2012; 22:1046-56.
  45. Saqr A, Sun H, Ostmann A, Vandyke R, Fenchel M, Clancy J. Cftr Biomarkers in Human and Murine Colonic Tissue: Similarities and Differences in Ion Transport and Protein Detection. Pediatric Pulmonology. 2012; 47:284-284.
  46. Sun H, Kotha K, Ostmann A, Clancy J. Acquired Cftr and Tmem16a Dysfunction in Vivo Associated with Tgf-Beta Activation. Pediatric Pulmonology. 2012; 47:284-284.
  47. Trapnell BC. Induced sputum biomarkers for monitoring cystic fibrosis lung disease. Am J Respir Crit Care Med. 2012; 186:812-4.
  48. VanDyke R, Clancy JP. Self-Modeling Structure of Intestinal Current Measurements in Patients with Cystic Fibrosis. Pediatric Pulmonology. 2012; 47:314-314.
  49. VanDyke R, McPhail GL, Fenchel M, Clancy JP, Amin R, Seid M. Feasible Statistical Monitoring to Identify Onset of Rapid Fev1 Decline and Facilitate Cystic Fibrosis Care Delivery. Pediatric Pulmonology. 2012; 47:387-387.
  50. Vandyke RD, McPhail GL, Huang B, Fenchel MC, Amin RS, Carle AC, Chini BA, Seid M. Inhaled tobramycin effectively reduces FEV1 decline in cystic fibrosis. An instrumental variables analysis. Ann Am Thorac Soc. 2013; 10:205-12.
  51. Woods JC. Mine the moon for 3He MRI? Not yet. J Appl Physiol. 2013; 114:705-6.
  52. Yuan Y, Yeh LK, Liu H, Yamanaka O, Hardie WD, Kao WW, Liu CY. Targeted overexpression of TGF-α in the corneal epithelium of adult transgenic mice induces changes in anterior segment morphology and activates noncanonical Wnt signaling. Invest Ophthalmol Vis Sci. 2013; 54:1829-37.